EV/EBITDA
4.54
+0.18+4.13%
15 min ago
Summary
- As of February 7, 2025, CTMX EV/EBITDA is 4.54, with a rise of +0.18 (+4.13%) during the most recent trading day.
- Over the past year, CTMX EV/EBITDA has increased by +26.29 (+120.87%).
- CTMX EV/EBITDA is now -82.60% below its all-time high of 26.09.
Performance
CTMX EV/EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
EV/EBITDA Formula
EV/EBITDA = Enterprise Value
TTM EBITDA
Enterprise Value
TTM EBITDA
TTM EBITDA
CTMX EV/EBITDA Trends
| PeriodPeriod | EV/EBITDAEV/EBITDA | Enterprise valueEnterprise value | PricePrice |
|---|---|---|---|
| todaytoday | +4.1% | +3.9% | +2.2% |
| 1 m1 month | -20.9% | -21.0% | -13.0% |
| 3 m3 months | -32.6% | -32.7% | -21.5% |
| 6 m6 months | -45.1% | -38.5% | -27.4% |
| ytdytd | -22.1% | -22.2% | -13.8% |
| 1 y1 year | +120.9% | -58.6% | -39.0% |
| 5 y5 years | +528.3% | -73.6% | -87.0% |
CTMX EV/EBITDA Highs & Lows
| PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
|---|---|---|---|---|---|
| 1 m | 1-month | -20.9% | 4.11 | +10.5% | |
| 3 m | 3-month | 8.39 | -45.9% | 4.11 | +10.5% |
| 6 m | 6-month | 9.30 | -51.2% | 4.11 | +10.5% |
| 1 y | 1-year | 26.09 | -82.6% | -42.01 | +110.8% |
| 3 y | 3-year | 26.09 | -82.6% | -42.01 | +110.8% |
| 5 y | 5-year | 26.09 | -82.6% | -42.01 | +110.8% |
| alltime | all time | 26.09 | -82.6% | -42.01 | +110.8% |
CytomX Therapeutics EV/EBITDA History
| Date | Value |
|---|---|
| 2025 | 4.54(-22.1%) |
| 2024 | 5.83(-124.0%) |
| 2023 | -24.25(-3666.2%) |
| 2022 | 0.68(-177.3%) |
| 2021 | -0.88(-53.9%) |
| Date | Value |
|---|---|
| 2020 | -1.91(+21.7%) |
| 2019 | -1.57(-72.5%) |
| 2018 | -5.70(-62.3%) |
| 2017 | -15.13(+189.3%) |
| 2016 | -5.23(-75.5%) |
| 2015 | -21.35 |
FAQ
- What is CytomX Therapeutics EV/EBITDA?
- What is the all time high EV/EBITDA for CytomX Therapeutics?
- What is CTMX EV/EBITDA year-to-date change?
- What is CytomX Therapeutics EV/EBITDA year-on-year change?
What is CytomX Therapeutics EV/EBITDA?
The current EV/EBITDA of CTMX is 4.54
What is the all time high EV/EBITDA for CytomX Therapeutics?
CytomX Therapeutics all-time high EV/EBITDA is 26.09
What is CTMX EV/EBITDA year-to-date change?
CytomX Therapeutics EV/EBITDA has changed by -1.29 (-22.13%) since the beginning of the year
What is CytomX Therapeutics EV/EBITDA year-on-year change?
Over the past year, CTMX EV/EBITDA has changed by +26.29 (+120.87%)